Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine, and High Dose Cytarabine (GCLAC) for Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome or Advanced Myeloproliferative Neoplasm

被引：0
|
作者：
Becker, Pamela S. [1 ]
Medeiros, Bruno C. [2 ]
Stein, Anthony Selwyn [3 ]
Appelbaum, Frederick R. [4 ]
Scott, Bart L. [5 ]
Delaney, Colleen [5 ,6 ]
Othus, Megan
Hendrie, Paul C.
Gardner, Kelda M. [5 ]
Petersdorf, Stephen [7 ]
Pagel, John M.
Walter, Roland B. [5 ]
Parks, Cynthia [1 ]
Estey, Elihu H. [5 ]
机构：
[1] Univ Washington, Div Hematol, Seattle, WA 98195 USA
[2] Stanford Comprehens Canc Ctr, Div Hematol, Stanford, CA USA
[3] City Hope Natl Med Ctr, Hematol & HCT, Duarte, CA USA
[4] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[5] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[6] UW, Dept Pediat, Seattle, WA USA
[7] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3594.3594
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3594
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 2 Trial of G-CSF Priming, Clofarabine, and High Dose Cytarabine (GCLAC) for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) or Advanced Myelodysplastic Syndrome or Advanced Myeloproliferative Neoplasm
    Becker, Pamela S.
    Medeiros, Bruno C.
    Appelbaum, Frederick R.
    Scott, Bart Lee
    Hendrie, Paul C.
    Storer, Barry
    Pierce, Sherry
    Petersdorf, Stephen H.
    Estey, Elihu H.
    BLOOD, 2011, 118 (21) : 1545 - 1545
  • [2] G-CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm
    Becker, Pamela S.
    Medeiros, Bruno C.
    Stein, Anthony S.
    Othus, Megan
    Appelbaum, Frederick R.
    Forman, Stephen J.
    Scott, Bart L.
    Hendrie, Paul C.
    Gardner, Kelda M.
    Pagel, John M.
    Walter, Roland B.
    Parks, Cynthia
    Wood, Brent L.
    Abkowitz, Janis L.
    Estey, Elihu H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (04) : 295 - 300
  • [3] G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2009, 114 (22) : 816 - 816
  • [4] Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Hendrie, Paul C.
    Pagel, John M.
    Stirewalt, Derek
    Shustov, Andrei
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2008, 112 (11) : 1018 - 1018
  • [5] Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
    W. K. Hofmann
    G. Heil
    C. Zander
    S. Wiebe
    O. G. Ottmann
    L. Bergmann
    K. Hoeffken
    J. T. Fischer
    A. Knuth
    K. Kolbe
    H. J. Schmoll
    W. Langer
    M. Westerhausen
    C. B. Koelbel
    D. Hoelzer
    A. Ganser
    Annals of Hematology, 2004, 83 : 498 - 503
  • [6] Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
    Hofmann, WK
    Heil, G
    Zander, C
    Wiebe, S
    Ottmann, OG
    Bergmann, L
    Hoeffken, K
    Fischer, JT
    Knuth, A
    Kolbe, K
    Schmoll, HJ
    Langer, W
    Westerhausen, M
    Koelbel, CB
    Hoelzer, D
    Ganser, A
    ANNALS OF HEMATOLOGY, 2004, 83 (08) : 498 - 503
  • [7] A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
    Halpern, Anna B.
    Othus, Megan
    Huebner, Emily M.
    Orlowski, Kaysey F.
    Scott, Bart L.
    Smith, Heather A.
    Becker, Pamela S.
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Perdue, Andrea M.
    Chen, Tara L.
    Buckley, Sarah A.
    Erba, Harry P.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2016, 128 (22)
  • [8] Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
    Becker, Pamela S.
    Kantarjian, Hagop M.
    Appelbaum, Frederick R.
    Petersdorf, Stephen H.
    Storer, Barry
    Pierce, Sherry
    Shan, Jianqin
    Hendrie, Paul C.
    Pagel, John M.
    Shustov, Andrei R.
    Stirewalt, Derek L.
    Faderl, Stephan
    Harrington, Elizabeth
    Estey, Elihu H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (02) : 182 - 189
  • [9] Multivariate Analysis of Response and Survival After Treatment with Clofarabine, Cytarabine and G-CSF Priming (GCLAC) In Relapsed/Refractory Acute Myeloid Leukemia (AML): Comparison with Prior Experience Using Fludarabine and Cytarabine Combination Regimens
    Becker, Pamela S.
    Kantarjian, Hagop
    Appelbaum, Frederick
    Petersdorf, Stephen H.
    Storer, Barry
    Pierce, Sherry A.
    Shan, Jianqin
    Hendrie, Paul C.
    Pagel, John M.
    Shustov, Andrei
    Stirewalt, Derek L.
    Faderl, Stefan
    Harrington, Elizabeth
    Estey, Elihu H.
    BLOOD, 2010, 116 (21) : 466 - 466
  • [10] Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia
    Kadia, Tapan M.
    Faderl, Stefan
    Ravandi, Farhad
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Konopleva, Marina
    Burger, Jan
    Huang, Xuelin
    Wang, Xuemei
    Pierce, Sherry
    Brandt, Mark
    Feliu, Jennie
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2015, 121 (14) : 2375 - 2382
12345